545 St Kilda Road MelbourneAustralia
Plus, Optiscan’s InVivage that is due to receive its FDA approval this year. After FDA approval in the United States of America (the biggest commercial market for such a device), CE approval in Europe will follow and finally TGA approval in Australia and elsewhere. Notwithstanding the huge Asian market for the technology.
ViewnVivo that allows single cell live 3D microscopic imaging for research purposes.
- Forums
- ASX - By Stock
- OIL
- Paula Fox Melanoma and Cancer Centre – New Project
Paula Fox Melanoma and Cancer Centre – New Project
Featured News
Add OIL (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.53M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 10.0¢ | $2.928K | 29.27K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 113063 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 220237 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 113063 | 0.100 |
5 | 54537 | 0.098 |
2 | 60000 | 0.097 |
2 | 55000 | 0.096 |
1 | 100000 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 220237 | 4 |
0.115 | 1600 | 1 |
0.120 | 143007 | 2 |
0.125 | 24007 | 1 |
0.130 | 58084 | 2 |
Last trade - 10.06am 27/05/2024 (20 minute delay) ? |
|
|||||
Last
10.5¢ |
  |
Change
0.000 ( 5.00 %) |
|||
Open | High | Low | Volume | ||
10.5¢ | 10.5¢ | 10.5¢ | 27667 | ||
Last updated 10.52am 27/05/2024 ? |
Featured News
OIL (ASX) Chart |